RubrYc has developed a unique molecular engineering approach to the discovery of epitope-selective antibodies. By combining greatly parallel in silico simulations, proprietary machine learning ...

JERUSALEM, Nov. 4 (Xinhua) -- Israeli researchers and their colleagues from the United States developed an antibody-based treatment that empowers the body's immune system to effectively attack cancer ...

The development is published in Nature Structural and Molecular Biology. It involves "engineering" llama antibodies ... animal trials this summer, with a view to starting clinical trials later ...